Bluebird Bio Company Profile

Aggregated data from the web about Bluebird Bio

Company Name	Bluebird Bio
Website	https://www.bluebirdbio.com
Snippet	The story of disease, treatment, and healthcare. The story we tell ourselves about what’s possible. Because things we may think of as permanent are actually open to reimagining and revising. Whether it’s science, the system, or even the parts of our body that let us down, we have the opportunity to start writing a different ending.
Type	Public company
Founded	1992
Revenue	$220 million (2020)[1]
Website	www.bluebirdbio.com
Founders	Philippe Leboulch and Irving London
Industry	BiotechnologyPharmaceutical industry
Products	Zynteglo
Traded as	Nasdaq: BLUE
Key people	Nick Leschly, President & CEOChip Baird, CFO
Net income	-$789 million (2019)
Headquarters	Cambridge, Massachusetts, U.S.
Total assets	$1.727 billion (2019)
Total equity	$1.284 billion (2019)
Number of employees	1,090 (2019)

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.